FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.21  |  FHIR Version n/a  User: [n/a]

34534111000001106: Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) (product)

Status: current, Not sufficiently defined by necessary conditions definition status. Date: 21-Jun 2017. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
104372201000001116 Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104372301000001113 Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) en Synonym Active Entire term case sensitive SNOMED CT United Kingdom drug extension module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction none true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has NHS dm+d (dictionary of medicines and devices) freeness indicator Sugar free true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Soluble tablet true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator Not available true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Memantine 5mg soluble tablets sugar free true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) VMP prescribing status (attribute) VMP invalid as a prescribable product true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) VMP non-availability indicator Available false Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has specific active ingredient Memantine hydrochloride true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Soluble tablet false Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Alzhok true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has active ingredient Memantine true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form Soluble tablet false Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has manufactured dose form Soluble tablet true Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Soluble tablet false Inferred relationship Existential restriction modifier
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Has dispensed dose form Soluble tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) 7 tablet Has AMP True Alzhok 5mg soluble tablets (Glenmark Pharmaceuticals Europe Ltd) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start